Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP2K7 Antikörper (AA 17-160)

MAP2K7 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7150725
  • Target Alle MAP2K7 Antikörper anzeigen
    MAP2K7 (Mitogen-Activated Protein Kinase Kinase 7 (MAP2K7))
    Bindungsspezifität
    • 26
    • 25
    • 8
    • 7
    • 7
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 17-160
    Reaktivität
    • 84
    • 54
    • 45
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 81
    • 6
    Kaninchen
    Klonalität
    • 67
    • 20
    Polyklonal
    Konjugat
    • 47
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MAP2K7 Antikörper ist unkonjugiert
    Applikation
    • 70
    • 35
    • 24
    • 23
    • 15
    • 14
    • 12
    • 11
    • 7
    • 6
    • 5
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF)
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Dual specificity mitogen-activated protein kinase kinase 7 protein (17-160AA)
    Isotyp
    IgG
    Top Product
    Discover our top product MAP2K7 Primärantikörper
  • Applikationshinweise
    Recommended dilution: WB:1:1000-1:5000, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    MAP2K7 (Mitogen-Activated Protein Kinase Kinase 7 (MAP2K7))
    Andere Bezeichnung
    MAP2K7 (MAP2K7 Produkte)
    Synonyme
    MAP2K7 antikoerper, 2 antikoerper, JNKK antikoerper, Jnkk2 antikoerper, Mapkk7 antikoerper, Mek7 antikoerper, Mkk7 antikoerper, MAPKK7 antikoerper, MKK7 antikoerper, PRKMK7 antikoerper, SAPKK-4 antikoerper, SAPKK4 antikoerper, 5930412N11Rik antikoerper, JNKK 2 antikoerper, MAPKK 7 antikoerper, MEK 7 antikoerper, Prkmk7 antikoerper, sek2 antikoerper, si:ch211-254d18.2 antikoerper, map2k7-A antikoerper, mitogen-activated protein kinase kinase 7 antikoerper, mitogen activated protein kinase kinase 7 antikoerper, mitogen-activated protein kinase kinase 7 L homeolog antikoerper, MAP2K7 antikoerper, Map2k7 antikoerper, map2k7 antikoerper, map2k7.L antikoerper
    Hintergrund

    Background: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

    Aliases: c-Jun N-terminal kinase kinase 2 antibody, Dual specificity mitogen activated protein kinase kinase 7 antibody, Dual specificity mitogen-activated protein kinase kinase 7 antibody, JNK activating kinase 2 antibody, JNK kinase 2 antibody, JNK-activating kinase 2 antibody, JNKK 2 antibody, Jnkk-2 antibody, Jnkk2 antibody, MAP kinase kinase 7 antibody, MAP2K7 antibody, MAPK/ERK kinase 7 antibody, MAPKK 7 antibody, MAPKK-7 antibody, MAPKK7 antibody, MEK 7 antibody, Mitogen Activated Protein Kinase kinase 7 antibody, MKK 7 antibody, MKK-7 antibody, MKK7 antibody, MP2K7_HUMAN antibody, PRKMK 7 antibody, PRKMK-7 antibody, PRKMK7 antibody, SAPK kinase 4 antibody, SAPKK-4 antibody, SAPKK4 antibody, Sek 2 antibody, Sek-2 antibody, Sek2 antibody, SKK4 antibody, stress-activated protein kinase kinase 4 antibody

    UniProt
    O14733
    Pathways
    MAPK Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, BCR Signaling
Sie sind hier: